Brief: Immutep Announces First Clinical Data From 90mg Dosing Of Efti
March 5 (Reuters) - Immutep Ltd IMM.AX :
* IMMUTEP ANNOUNCES FIRST CLINICAL DATA FROM 90MG DOSING OF
EFTI
* IMMUTEP LTD - DATA FROM SAFETY LEAD-IN OF AIPAC-003 TRIAL
SHOWS
90MG EFTI IN COMBINATION WITH PACLITAXEL IS SAFE AND WELL
TOLERATED
Source text for Eikon: ID:nGNX55VDkB
Further company coverage: IMM.AX
((Reuters.Briefs@thomsonreuters.com;))